Description: SurModics, Inc. provides drug delivery and surface modification technologies to the healthcare industry. The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. It also provides in vitro diagnostic component products and technologies comprising protein stabilization reagents, substrates, polymers and reagent chemicals, antigens, and surface coatings for diagnostic test kits and biomedical research applications. SurModics, Inc. markets its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Home Page: www.surmodics.com
SRDX Technical Analysis
9924 West 74th Street
Eden Prairie,
MN
55344-3523
United States
Phone:
952 500 7000
Officers
Name | Title |
---|---|
Mr. Gary R. Maharaj | CEO, Pres & Director |
Mr. Timothy J. Arens | Sr. VP of Fin. & Information Technology and CFO |
Mr. Gordon S. Weber | Sr. VP of Legal, Gen. Counsel & Sec. |
Mr. Joseph J. Stich | Sr. VP of HR & Pres of In Vitro Diagnostics |
Ms. Teryl L. W. Sides | Sr. VP & Pres of Vascular Interventions |
Mr. John D. Manders | Corp. Controller, VP of Fin. & Principal Accounting Officer |
Mr. Charles W. Olson | Sr. VP & Pres of Medical Device Coatings |
Mr. Gregg S. Sutton | VP of R&D - Medical Devices |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 81.9672 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 4.6631 |
Price-to-Sales TTM: | 5.0527 |
IPO Date: | 1998-03-04 |
Fiscal Year End: | September |
Full Time Employees: | 447 |